Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 28 Colorectal Neoplasms 13 Colonic Neoplasms 13 Rectal Neoplasms 9 Prostatic Neoplasms 7 Head and Neck Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Uterine Cervical Neoplasms 5 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Melanoma 5 Endometrial Neoplasms 5 Central Nervous System Neoplasms 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Lung Neoplasms 4 Kidney Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Pancreatic Neoplasms 3 Neuroblastoma 3 Liver Neoplasms 3 Liposarcoma 3 Hemangiosarcoma 3 Hemangiopericytoma, Malignant 3 Gallbladder Neoplasms 3 Fibrosarcoma 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Hepatocellular 3

Interventions

Mitotane 4 Etoposide 3 Cisplatin 3 Doxorubicin 2 pegfilgrastim 1 Streptozocin 1 Platinum 1 Observation 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Fentanyl 1 Ethane 1 Dichlorodiphenyldichloroethane 1 Chemotherapy, Adjuvant 1 3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Adrenocortical Carcinoma × Chemotherapy, Adjuvant × Clear all

NCT03723941 2024-08-01

ACACIA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 3 Completed

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡